Search

Your search keyword '"Pasquet, Marlène"' showing total 286 results

Search Constraints

Start Over You searched for: Author "Pasquet, Marlène" Remove constraint Author: "Pasquet, Marlène"
286 results on '"Pasquet, Marlène"'

Search Results

1. Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency

5. Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus

7. Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias

8. Association of paediatric autoimmune cytopenia and inflammatory bowel disease suggests a common genetic origin.

9. Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome

10. Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients

11. Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation

12. Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance

13. Antinuclear antibodies associated auto-immune cytopenia in childhood is a risk factor for systemic lupus erythematosus

15. LOSS OF HSC STEMNESS IDENTITY IS ASSOCIATED WITH EXHAUSTION AND HYPORESPONSIVENESS IN GATA2 DEFICIENCY SYNDROME

16. Stem cell–like reprogramming is required for leukemia-initiating activity in B-ALL

18. Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes

19. Prospective validation of an equation based on plasma cystatin C for monitoring the glomerular filtration rate in children treated with cisplatin or ifosfamide for cancer

20. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice

21. Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond–like syndrome

22. Burden of Poor Health Conditions and Quality of Life in 656 Children with Primary Immunodeficiency

23. Neurological Involvement in Childhood Evans Syndrome

24. Cutaneous and Visceral Chronic Granulomatous Disease Triggered by a Rubella Virus Vaccine Strain in Children With Primary Immunodeficiencies

26. OC 9 - HOMOZYGOUS CBL MUTATION IN B LYMPHOCYTES AFTER CBL-DRIVEN JMML IMPAIRS B CELL MATURATION, FUNCTION AND ANTIBACTERIAL IMMUNITY

27. Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia

28. Late-onset pulmonary complications following allogeneic hematopoietic cell transplantation in pediatric patients: a prospective multicenter study

29. Recommandations: Infections fongiques invasives chez l’enfant immunodéprimé en hématologie pédiatrique : recommandations de prise en charge au sein des centres de la SFCE

32. Molecular and clinicopathologic characterization of pediatric histiocytoses.

34. An appraisal of the frequency and severity of noninfectious manifestations in primary immunodeficiencies: A study of a national retrospective cohort of 1375 patients over 10 years

35. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia

40. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

41. CELL QUIESCENCE AND REPROGRAMMING ARE DISTINCTIVE FEATURES OF PRE- LEUKEMIC STEM CELLS IN BACUTE LYMPHOBLASTIC LEUKEMIA

43. Novel Insights into Pediatric Acute Lymphoblastic Leukemia Ophthalmic Relapses from a Nationwide Cohort Study

44. 3084 – CELL QUIESCENCE AND REPROGRAMMING ARE DISTINCTIVE FEATURES OF PRE-LEUKEMIC STEM CELLS IN B-ACUTE LYMPHOBLASTIC LEUKEMIA

45. Hematological Involvement in Childhood Langerhans Cell Histiocytosis: A Cohort Study of 303 Patients

47. Childhood ovarian nonseminomatous germ cell tumors: A highly curable disease with few long‐term treatment‐related toxicities—Results of the French TGM95 study

48. Pediatric-Onset Evans Syndrome Is Associated with Broad Immunopathological Manifestations, High Treatment Burden and Mortality in Long-Term Follow-up

50. Single‐dose (4.5 mg/m2) gemtuzumab ozogamicin in combination with fludarabine, cytarabine and anthracycline as reinduction therapy in relapsed or refractory paediatric acute myeloid leukaemia.

Catalog

Books, media, physical & digital resources